The EU Parliament voted its position on the Unitary SPC
by Giuliana Miglierini The intersecting pathways of revision of the pharmaceutical and intellectual property legislations recently marked the…
The FDA warns about the manufacture medicinal and non-pharmaceutical products on the same equipment
by Giuliana Miglierini A Warning Letter, sent in September 2022 by the US FDA to a German company…
Key issues in technical due diligences
by Giuliana Miglierini Financial due diligence is a central theme when discussing mergers and acquisitions (M&A). Not less…